The Circulating Micro-RNAs (−122, −34a and −99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases
Olfat M Hendy,1 Hatem Rabie,1 Amr El Fouly,2 Mohamed Abdel-Samiee,3 Nashwa Abdelmotelb,1 Amr Aly Elshormilisy,4 Mahmoud Allam,3 Samia Taher Ali,5 Nessren Mohamed Bahaa EL-Deen,6 Shimaa Abdelsattar,7 Somia Mokabel Mohamed8 1Clinical Pathology Department, National Liver Institute, Menoufia University,...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/96af71c5ac7a4908a3a15242b8004949 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:96af71c5ac7a4908a3a15242b8004949 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:96af71c5ac7a4908a3a15242b80049492021-12-02T02:37:45ZThe Circulating Micro-RNAs (−122, −34a and −99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases1178-7007https://doaj.org/article/96af71c5ac7a4908a3a15242b80049492019-12-01T00:00:00Zhttps://www.dovepress.com/the-circulating-micro-rnas-minus122-minus34a-and-minus99a-as-predictiv-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Olfat M Hendy,1 Hatem Rabie,1 Amr El Fouly,2 Mohamed Abdel-Samiee,3 Nashwa Abdelmotelb,1 Amr Aly Elshormilisy,4 Mahmoud Allam,3 Samia Taher Ali,5 Nessren Mohamed Bahaa EL-Deen,6 Shimaa Abdelsattar,7 Somia Mokabel Mohamed8 1Clinical Pathology Department, National Liver Institute, Menoufia University, Shebin El-Kom, Egypt; 2Endemic Medicine Department, Helwan University, Cairo, Egypt; 3Hepatology and Gastroenterology Department, National Liver Institute, Menoufia University, Shebin El-Kom, Egypt; 4Internal Medicine Department, Helwan University, Cairo, Egypt; 5Internal Medicine Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt; 6Tropical Medicine Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt; 7Department of Clinical Biochemistry, National Liver Institute, Menoufia University, Shebin El-Kom, Egypt; 8Department of Physiology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, EgyptCorrespondence: Mohamed Abdel-SamieeNational Liver Institute, Yassin Abdel-Ghafar Street, Shebin El-Kom, Menoufia 32511, EgyptTel +2048 2222740Fax +2048 2234685Email Drmohammed100@yahoo.comBackground: It remains essential for patient safety to develop non-invasive diagnostic tools to diagnose non-alcoholic fatty liver rather than invasive techniques.Aim: Our case-control study was to address the value of circulating miRNAs as a potential non-invasive biomarker for the diagnosis of non-alcoholic fatty acid diseases (NAFLD) and monitoring of disease progression.Methods: Routine clinical assessment, laboratory tests, anthropometric study, and liver biopsy results reported for 210 patients with NAFLD (124 patients of simple steatosis (SS) and 86 of non-alcoholic steatohepatitis (NASH)). Apparently matched for age and gender, healthy participants (n= 90) were enrolled as a control group. Serum samples were tested for micro-RNAs (−122, −34a and −99a) by quantitative-PCR.Results: By histopathology, 124 of the NAFLD group were of SS and 86 patients were of NASH. Compared with the control subjects, both mi-RNA-122 and −34a levels were increased in NAFLD (p< 001) and at a cut-off = 1.261, mi-RNA-122 had 92% sensitivity, 85% specificity to differentiate NAFLD from healthy controls, while mi-RNA-99a were significantly decreased in NAFLD patients with an observed decrease in disease severity, and at a cut-off = 0.46, miRNA-99a had 94% sensitivity and 96% specificity to discriminate SS from NASH.Conclusion: The integration of a circulating mi-RNA panel to diagnose NAFLD cases and to discriminate between SS and NASH. Large-scale study is still needed to verify the other mi-RNA profiles and their role in NAFLD pathogenesis and targeting therapy.Keywords: NASH, NAFLD, micro-RNA, simple steatosisHendy OMRabie HEl Fouly AAbdel-Samiee MAbdelmotelb NElshormilisy AAAllam MAli STBahaa EL-Deen NMAbdelsattar SMohamed SMDove Medical Pressarticlenashnafldmicro-rnasimple steatosis.Specialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 12, Pp 2715-2723 (2019) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
nash nafld micro-rna simple steatosis. Specialties of internal medicine RC581-951 |
| spellingShingle |
nash nafld micro-rna simple steatosis. Specialties of internal medicine RC581-951 Hendy OM Rabie H El Fouly A Abdel-Samiee M Abdelmotelb N Elshormilisy AA Allam M Ali ST Bahaa EL-Deen NM Abdelsattar S Mohamed SM The Circulating Micro-RNAs (−122, −34a and −99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases |
| description |
Olfat M Hendy,1 Hatem Rabie,1 Amr El Fouly,2 Mohamed Abdel-Samiee,3 Nashwa Abdelmotelb,1 Amr Aly Elshormilisy,4 Mahmoud Allam,3 Samia Taher Ali,5 Nessren Mohamed Bahaa EL-Deen,6 Shimaa Abdelsattar,7 Somia Mokabel Mohamed8 1Clinical Pathology Department, National Liver Institute, Menoufia University, Shebin El-Kom, Egypt; 2Endemic Medicine Department, Helwan University, Cairo, Egypt; 3Hepatology and Gastroenterology Department, National Liver Institute, Menoufia University, Shebin El-Kom, Egypt; 4Internal Medicine Department, Helwan University, Cairo, Egypt; 5Internal Medicine Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt; 6Tropical Medicine Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt; 7Department of Clinical Biochemistry, National Liver Institute, Menoufia University, Shebin El-Kom, Egypt; 8Department of Physiology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, EgyptCorrespondence: Mohamed Abdel-SamieeNational Liver Institute, Yassin Abdel-Ghafar Street, Shebin El-Kom, Menoufia 32511, EgyptTel +2048 2222740Fax +2048 2234685Email Drmohammed100@yahoo.comBackground: It remains essential for patient safety to develop non-invasive diagnostic tools to diagnose non-alcoholic fatty liver rather than invasive techniques.Aim: Our case-control study was to address the value of circulating miRNAs as a potential non-invasive biomarker for the diagnosis of non-alcoholic fatty acid diseases (NAFLD) and monitoring of disease progression.Methods: Routine clinical assessment, laboratory tests, anthropometric study, and liver biopsy results reported for 210 patients with NAFLD (124 patients of simple steatosis (SS) and 86 of non-alcoholic steatohepatitis (NASH)). Apparently matched for age and gender, healthy participants (n= 90) were enrolled as a control group. Serum samples were tested for micro-RNAs (−122, −34a and −99a) by quantitative-PCR.Results: By histopathology, 124 of the NAFLD group were of SS and 86 patients were of NASH. Compared with the control subjects, both mi-RNA-122 and −34a levels were increased in NAFLD (p< 001) and at a cut-off = 1.261, mi-RNA-122 had 92% sensitivity, 85% specificity to differentiate NAFLD from healthy controls, while mi-RNA-99a were significantly decreased in NAFLD patients with an observed decrease in disease severity, and at a cut-off = 0.46, miRNA-99a had 94% sensitivity and 96% specificity to discriminate SS from NASH.Conclusion: The integration of a circulating mi-RNA panel to diagnose NAFLD cases and to discriminate between SS and NASH. Large-scale study is still needed to verify the other mi-RNA profiles and their role in NAFLD pathogenesis and targeting therapy.Keywords: NASH, NAFLD, micro-RNA, simple steatosis |
| format |
article |
| author |
Hendy OM Rabie H El Fouly A Abdel-Samiee M Abdelmotelb N Elshormilisy AA Allam M Ali ST Bahaa EL-Deen NM Abdelsattar S Mohamed SM |
| author_facet |
Hendy OM Rabie H El Fouly A Abdel-Samiee M Abdelmotelb N Elshormilisy AA Allam M Ali ST Bahaa EL-Deen NM Abdelsattar S Mohamed SM |
| author_sort |
Hendy OM |
| title |
The Circulating Micro-RNAs (−122, −34a and −99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases |
| title_short |
The Circulating Micro-RNAs (−122, −34a and −99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases |
| title_full |
The Circulating Micro-RNAs (−122, −34a and −99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases |
| title_fullStr |
The Circulating Micro-RNAs (−122, −34a and −99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases |
| title_full_unstemmed |
The Circulating Micro-RNAs (−122, −34a and −99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases |
| title_sort |
circulating micro-rnas (−122, −34a and −99a) as predictive biomarkers for non-alcoholic fatty liver diseases |
| publisher |
Dove Medical Press |
| publishDate |
2019 |
| url |
https://doaj.org/article/96af71c5ac7a4908a3a15242b8004949 |
| work_keys_str_mv |
AT hendyom thecirculatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT rabieh thecirculatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT elfoulya thecirculatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT abdelsamieem thecirculatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT abdelmotelbn thecirculatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT elshormilisyaa thecirculatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT allamm thecirculatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT alist thecirculatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT bahaaeldeennm thecirculatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT abdelsattars thecirculatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT mohamedsm thecirculatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT hendyom circulatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT rabieh circulatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT elfoulya circulatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT abdelsamieem circulatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT abdelmotelbn circulatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT elshormilisyaa circulatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT allamm circulatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT alist circulatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT bahaaeldeennm circulatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT abdelsattars circulatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases AT mohamedsm circulatingmicrornasminus122minus34aandminus99aaspredictivebiomarkersfornonalcoholicfattyliverdiseases |
| _version_ |
1718402305669201920 |